AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own 1st Source today, you really have to believe that its improving net interest margin, disciplined credit culture and focus on niche lending can keep compounding value even as growth expectations cool. The latest quarter, with seventh consecutive net interest margin expansion, record earnings and better credit quality, reinforces that near term catalyst, especially when paired with a higher dividend and steady revenue growth. At the same time, leadership transitions at both the CEO and risk officer levels, plus insider share sales, keep management execution firmly in focus as a risk. Compared with pre-news analysis, the earnings strength arguably supports the case for a re-rating, but the softer long term growth forecasts and recent underperformance versus peers suggest any rerating could be gradual rather than rapid.
However, management turnover at a time of shifting growth expectations is something investors should not overlook. 1st Source's shares have been on the rise but are still potentially undervalued by 49%. Find out what it's worth.Explore 3 other fair value estimates on 1st Source - why the stock might be a potential multi-bagger!
Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com